rx 821002 has been researched along with racemetirosine in 1 studies
Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (racemetirosine) | Trials (racemetirosine) | Recent Studies (post-2010) (racemetirosine) |
---|---|---|---|---|---|
317 | 0 | 45 | 1,165 | 45 | 96 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Farley, JT; Klimek, V; Ordway, GA; Zhang, W; Zhu, MY | 1 |
1 other study(ies) available for rx 821002 and racemetirosine
Article | Year |
---|---|
alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenergic alpha-Antagonists; alpha-Methyltyrosine; Animals; Cell Line; Colforsin; Corpus Striatum; Crosses, Genetic; Cyclic AMP; Dopamine; Enzyme Activation; Homozygote; Idazoxan; In Vitro Techniques; Kinetics; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Knockout; Norepinephrine; Rats; Receptors, Adrenergic, alpha-2; Recombinant Proteins; Reserpine; Transfection | 1999 |